SCHEMBL8339781

SCHEMBL8339781

COc1cc(CC(C)(C)C)cc(O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.50
TNKS2 Q9H2K2 2/20 0.49
TNKS O95271 1/20 0.49
TSHR P16473 2/20 0.44
TAAR1 Q96RJ0 2/20 0.44
MAPK1 P28482 1/20 0.44
ADRB2 P07550 1/20 0.44
LMNA P02545 3/20 0.43
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 1/20 0.43
NFKB1 P19838 1/20 0.43
GLA P06280 1/20 0.43
PTGS2 P35354 1/20 0.43
MEN1 O00255 1/20 0.42
APEX1 P27695 1/20 0.42
KMT2A Q03164 1/20 0.42
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339208 0.92 AKR1B1 (0.49) AKR1B1TNKS2TNKSLMNAKMT2A
SCHEMBL12867176 0.87 ALOX5 (0.44) AKR1B1TNKS2TNKSTSHRTAAR1
SCHEMBL8337638 0.85 TUBB4A (0.50) CYP3A4PTGS2TUBB4ATUBBTUBA3C
SCHEMBL12775669 0.84 TRPV1 (0.46) AKR1B1TNKS2MEN1KMT2AGAA
SCHEMBL6349366 0.83 ESR1 (0.50) TSHRTAAR1MAPK1ADRB2LMNA
SCHEMBL8342475 0.79 TAAR1 (0.61) TSHRTAAR1MAPK1LMNACYP3A4
SCHEMBL10062369 0.78 PTGS2 (0.59) AKR1B1TNKS2TNKSTSHRTAAR1
SCHEMBL17263518 0.78 AKR1B1 (0.76) AKR1B1TNKS2TNKSTSHRTAAR1
SCHEMBL14770056 0.78 MEN1 (0.39) PTGS2MEN1KMT2AESR1KDM4E
SCHEMBL10285344 0.78 AKR1B1 (0.55) AKR1B1TNKS2TNKSTSHRTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004043367-A2 FUSED HETEROCYCLIC COMPOUNDS AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2004-05-27 WO disclosed